Bavarian Nordic: MCM

Bavarian Nordic secured up to $40 million from the US government for funding on clinical and preclinical testing of their freeze dried Imvamune Smallpox vaccine. Funding would also be used to validate the new freeze dried manufacturing process.

Bavarian Nordic secured up to $40 million from the US government for funding on clinical and preclinical testing of their freeze dried Imvamune Smallpox vaccine. Funding would also be used to validate the new freeze dried manufacturing process.

As reported in the October news, Human Genome and the FDA’s relationship gets worse as they deny approval for their ABthrax product. Quite what this means for the $160 million that has already been spent on ABthrax is unclear.


--------------------------------------------------------------------------------

Our Current Sponsors

  • Flir
  • BioFire Defense
  • Federal Resources
  • Cristanini
  • Airboss
  • Flir
  • Argon
  • 908 Devices
  • Avon
  • Battelle
  • Flir
  • Bw Tek
  • CQC
  • Decon Seven Systems
  • DQE
  • Flir
  • Dxterity
  • First Line Technology
  • Futurtech
  • Metrohm Raman
  • Flir
  • NBC sys
  • Proengin
  • Qinetiq
  • Tex Shield
  • Flir
  • Wl Gore
  • ADS, Inc.
  • Rigaku Analytical Devices
  • Paul Boye Technologies
  • Flir
  • Observis
  • Zeteo Tech
  • Bertin Instruments
  • ECOTEST